3,5-Dimethylpiperidine, mixture of cis and trans ≥96%

Properties

Related Categories	Building Blocks, C5 to C7, Chemical Synthesis, Heterocyclic Building Blocks, Piperidines More...
assay	≥96%
refractive index	n20/D 1.4454(lit.)
bp	144 °C(lit.)
density	0.853 g/mL at 25 °C(lit.)

Description

Packaging

25 g in glass bottle

Application

Reactant for synthesis of:
Substituted bisphenol A derivatives as β-amyloid peptide aggregation inhibitors¹
MMP-13 selective isonipecotamide α-sulfone hydroxamates²
Gem-diamines for active organocatalysts for biodiesel production³
Benzimidazole inhibitors of the antigen receptor-mediated NF-κB⁴

Reactant for Mannich reactions to form Ru(II) complexes⁵

Price and Availability

Related Papers

1. Structural optimization and biological evaluation of substituted bisphenol A derivatives as beta-amyloid peptide aggregation inhibitors. Y. Zhou, et al., J. Med. Chem. 53, 5449-5466, (2010)

Documents

Certificate of Analysis

Certificate of Origin

FT-IR Condensed Phase

FT-IR Raman

FT-NMR

Pressure-Temperature Nomograph

Safety Information

Symbol	GHS02, GHS07
Signal word	Warning
Hazard statements	H226-H315-H319-H335
Precautionary statements	P261-P305 + P351 + P338
Personal Protective Equipment	Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
Hazard Codes (Europe)	Xi
Risk Statements (Europe)	10-36/37/38
Safety Statements (Europe)	16-26-36/37/39
RIDADR	UN 1993 3/PG 3
WGK Germany	3
Flash Point(F)	91.4 °F
Flash Point(C)	33 °C

Technical information & documentation associated with this product is available in the Safety & Documentation tab.

Papers

Set your institution to view full text papers.

1. Structural optimization and biological evaluation of substituted bisphenol A derivatives as beta-amyloid peptide aggregation inhibitors. Y. Zhou, et al., J. Med. Chem. 53, 5449-5466, (2010)

Loading...

2. MMP-13 selective isonipecotamide alpha-sulfone hydroxamates. S. A. Kolodziej, et al., Bioorg. Med. Chem. Lett. 20, 3561-3564, (2010)

Loading...

3. M. Cerro-Alarcon, et al., Appl. Catal. 382, 36-42, (2010)

4. Selective benzimidazole inhibitors of the antigen receptor-mediated NF-kappaB activation pathway. K. J. Okolotowicz, et al., Bioorg. Med. Chem. 18, 1918-1924, (2010)

Loading...

5. J. H. Kasser, et al., J. Organomet. Chem. 695, 875-881, (2010)

Aldrich MSDS 1, 796:C / Corp MSDS 1 (1), 1410:A / FT-IR 2 (1), 564:C / FT-IR 1 (1), 360:D / FT-NMR 1 (1), 568:C / IR-Spectra (3), 212:D / NMR-Reference 2 (1), 316:C / RegBook 1 (1), 383:L / Structure Index 1, 54:A:9 / Vapor Phase 3, 452:B